TrakCel & McKesson partner to help commercialize gene & cell therapy
Category: #research  By Nikita Chaurasia  Date: 2019-09-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

TrakCel & McKesson partner to help commercialize gene & cell therapy
  • The combination of these two product suites is designed specifically for the growing number of developers that are nearing the commercial launch of gene and cell therapies.
  • The integrated platform allows the product scale-up towards market delivery including automatic product-specific workflow scheduling across multiple care team members and supply chain partners.

McKesson, a leading provider of patient access support, third-party logistic (3PL) services as well as specialty pharmacy solutions, and TrakCel, software developing firm for gene and cell therapy orchestration and supply chain tracking systems, reportedly announced a collaboration to help late-stage developers of gene and cell therapy.

The collaboration will combine both companies’ patient access services and supply chain tracking to allow a more effective path for the industry players to develop next-gen commercial therapies.

Integrating TrakCel’s personalized drug orchestration software and data tracking system with the capabilities of McKesson’s current high-touch platform for patients, as well as both the companies’ support and expertise, will give an end-to-end solution for the gene and cell therapy industry to manage the entirety of the therapeutic supply chain.

McKesson and TrakCel would start by developing a basic solution design. Both these integrated solutions will further be offered to individual company clients which would then benefit specifically from this combined solution.

The combination of these two product suites is particularly designed for the growing number of developers that are approaching commercial launch of their gene and cell therapies. The integrated platform allows the product scale-up towards market delivery.

This also involves automated scheduling of product-centric workflows across numerous care team members and supply chain partners, and a validated tracking of chain-of-identity to ensure delivery of the right drug product. These capabilities guarantee that the patient gets the right, uncompromised treatment at the correct time.

Layne Martin, VP/GM of Specialty Distribution Solutions at McKesson Life Sciences stated that the integrated system would help manufacturers and prescribers work together in a seamless manner to ensure that right patient always gets the right therapeutic product and at the correct time.

Source credit: https://www.businesswire.com/news/home/20190911005059/en/McKesson-TrakCel-Launch-Innovative-Collaboration-Support-Commercialization

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Google to settles fiscal fraud probe with French authorities
Google to settles fiscal fraud probe with French authorities
By Nikita Chaurasia

The company has decided to pay 1 billion euros to the French regulators, considerably less than the 1.6 billion euros that it had to pay for the raid in 2016. Google LLC, a multinational tech company that offers internet-related services, has decid...

TOI & CareMore care model showcases better cancer care at lower cost
TOI & CareMore care model showcases better cancer care at lower cost
By Nikita Chaurasia

The study registered CareMore patients that were newly diagnosed with hematologic and solid malignancies from November 2016 to September 2018.   The cancer care model which is value-based used LHWs, they are non-physician community members w...

Seoul Semiconductor files patent breach claim against Conrad
Seoul Semiconductor files patent breach claim against Conrad
By Nikita Chaurasia

The South Korean company sued a European electronic products retailer on account of the violation of patented backlight unit LEDs.   The lawsuit filed is aimed to secure the second-generation LED technology. A South Korea based LED manufac...